COCP vs EXC · rev $105.0K vs P/E 17, rev $24.26B
Cocrystal Pharma Inc (COCP) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
COCP currently screens at market cap $13.3M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the COCP and EXC stock pages for the full models.
Not investment advice.